Lothar Lindemann
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Receptor Mechanisms and Signaling 15
- Ubiquitin and proteasome pathways 4
-
- Neuroscience and Neuropharmacology Research 12
- Neuropeptides and Animal Physiology 4
- Co-authors
- Marius C. Hoener (10 shared papers)Joseph G. Wettstein (7 shared papers)Georg Jaeschke (9 shared papers)Will Spooren (5 shared papers)Mark F. Bear (4 shared papers)Laurence Ozmen (3 shared papers)Aubin Michalon (4 shared papers)Theresa M. Ballard (2 shared papers)
- Journals
- Neuropharmacology (3 papers)Trends in Pharmacological Sciences (2 papers)Drug Safety (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Nature Reviews Drug Discovery (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Lothar Lindemann
34 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 110
- Biological Psychiatry 217
- Cellular and Molecular Neuroscience 1.2k
- Cognitive Neuroscience 883
- Genetics 945
- Sensory Systems 163
Countries citing papers authored by Lothar Lindemann
This map shows the geographic impact of Lothar Lindemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Lindemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Lindemann more than expected).
Fields of papers citing papers by Lothar Lindemann
This network shows the impact of papers produced by Lothar Lindemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Lindemann. The network helps show where Lothar Lindemann may publish in the future.
Co-authors
The 25 scholars most cited alongside Lothar Lindemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 375 | |
| 2 | 2017 | 273 | |
| 3 | 2007 | 258 | |
| 4 | 2017 | 233 | |
| 5 | 2005 | 214 | |
| 6 | 2005 | 202 | |
| 7 | 2008 | 126 | |
| 8 | 2012 | 100 | |
| 9 | 2017 | 93 | |
| 10 | 2011 | 91 | |
| 11 | 2015 | 87 | |
| 12 | 2014 | 84 | |
| 13 | 2011 | 83 | |
| 14 | 2013 | 79 | |
| 15 | 2013 | 62 | |
| 16 | 2005 | 50 | |
| 17 | 2013 | 48 | |
| 18 | 2013 | 45 | |
| 19 | 2011 | 44 | |
| 20 | 2010 | 40 |
About Lothar Lindemann
Lothar Lindemann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Genetics, Cognitive Neuroscience and Biological Psychiatry, having authored 38 papers that have together received 2.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (15 papers), Neuroscience and Neuropharmacology Research (12 papers), Genetics and Neurodevelopmental Disorders (10 papers), Autism Spectrum Disorder Research (6 papers), Neuropeptides and Animal Physiology (4 papers), Tryptophan and brain disorders (4 papers), Influenza Virus Research Studies (4 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Biological Psychiatry (217 citations), Cellular and Molecular Neuroscience (1.2k citations), Cognitive Neuroscience (883 citations), Genetics (945 citations) and Sensory Systems (163 citations). Lothar Lindemann has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Marius C. Hoener, Joseph G. Wettstein, Georg Jaeschke, Will Spooren, Mark F. Bear, Laurence Ozmen, Aubin Michalon, Theresa M. Ballard, Michael S. Sidorov and Martin Ebeling. Their work appears in journals such as Neuropharmacology, Trends in Pharmacological Sciences, Drug Safety, Journal of Pharmacology and Experimental Therapeutics and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.